Infection
Infection occurs when pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, invade a host organism and multiply, causing disease. Throughout human history, infections have been a dominant force shaping human evolution, acting as powerful selective pressures on our genomes by historically removing individuals most susceptible to severe disease.[1]However, with the advent of mandatory vaccinations, improved sanitary conditions, better pathogen control, and more effective clinical treatments, recent generations have seen a shift in these pressures. This has led to the retention and accumulation of certain disease-associated genetic variants within populations.[1]Understanding the genetic basis of susceptibility to infection is crucial for predicting individual risk and developing targeted interventions.
Biological Basis of Susceptibility
Section titled “Biological Basis of Susceptibility”The susceptibility of an individual to infection is significantly influenced by their host genetic factors, which dictate the intricate interaction between the host and the invading pathogen.[1]Research indicates that the genetic architecture underlying susceptibility to infection is largely polygenic, meaning it involves multiple genes working in concert.[1]Both common and rare genetic variants contribute to this susceptibility. Rare variants, in particular, hold promise for predicting individualized infection disease risk based on their accumulation.[1] Genome-wide association studies (GWAS) have been instrumental in uncovering specific genetic loci associated with susceptibility to various common infections. For instance, studies have identified numerous genome-wide significant regions, including those within the Human Leukocyte Antigen (HLA) region, which plays a critical role in immune response.[2] Specific genes implicated include IL4 in respiratory infections.[3]and an intronic single-nucleotide polymorphism (SNP)rs6447952 in the SLIT2 gene, known for its roles in both immunity and neurodevelopment.[3] These findings highlight the complex interplay of genetic factors in determining how individuals respond to infectious agents.
Clinical and Social Relevance
Section titled “Clinical and Social Relevance”The identification of genetic variants linked to infection susceptibility carries substantial clinical and social importance. Clinically, identifying rare variants with strong effects can become an invaluable tool for predicting an individual’s risk of being infected with specific pathogens.[1]This allows for the prediction of individualized infection disease risk, potentially guiding preventive measures, personalized treatment strategies, or closer monitoring for high-risk individuals. Large-scale studies, such as those utilizing nationwide population-based registers, enhance the power and validity of these genetic discoveries, providing a robust foundation for understanding general genetic pathways for susceptibility to various infections.[3]From a societal perspective, understanding the genetic landscape of infection susceptibility is vital for public health. The insights gained can inform strategies for managing current and future epidemics, particularly given the potential for (re-)emerging epidemics to exploit similar susceptibility mechanisms.[1]Research has identified susceptibility loci for a wide range of common infections, including chickenpox, cold sores, mononucleosis, hepatitis B, plantar warts, positive TB tests, strep throat, scarlet fever, and bacterial meningitis.[2]Furthermore, emerging research also explores potential genetic links between susceptibility to infection and other health conditions, such as mental disorders, underscoring the broad impact of infectious diseases on overall health and well-being.[3]
Methodological Constraints and Accuracy
Section titled “Methodological Constraints and Accuracy”The accuracy of genotype calling presents a significant limitation in large-scale genetic studies, including those investigating infection. Small systematic differences in data sets can readily produce effects capable of obscuring true associations, necessitating extensive quality control measures to minimize experimental variations and ensure robust findings.[4] Despite the implementation of sophisticated genotype-calling algorithms, infallible detection of incorrect genotype calls remains unachievable, requiring a careful compromise between stringent criteria (which might inadvertently discard true signals) and leniency (which risks swamping genuine findings with spurious results due to poor genotype calling).[4]Consequently, interpretations of genetic variants linked to infection must consider these inherent challenges in distinguishing genuine biological signals from technical artifacts, potentially impacting the reliability and reproducibility of discovered associations.
Population Structure and Generalizability
Section titled “Population Structure and Generalizability”A crucial limitation for interpreting genetic associations with infection stems from the potential for population structure to undermine inferences in case-control association studies.[4]Differences in ancestral backgrounds between study participants, even subtle ones, can lead to spurious associations or mask true genetic effects, thereby introducing cohort bias. This stratification makes it challenging to generalize findings regarding infection risk across diverse populations, as genetic variants identified in one population might not exhibit the same effect size or frequency in another. Therefore, the applicability of observed genetic links to infection requires careful consideration of the specific population studied and validation in broader, ethnically diverse cohorts to ensure wider relevance.
Variants
Section titled “Variants”Genetic variations play a crucial role in determining an individual’s susceptibility to various diseases, including infectious conditions, by influencing gene function and cellular processes. Among these, variants impacting chromatin remodeling, signaling, and gene regulation are particularly relevant. For instance, RSF1 (Remodeling and Spacing Factor 1) is a critical component of a chromatin remodeling complex that helps regulate gene expression by modifying chromatin structure. A variant like rs146072725 in RSF1 could potentially alter this delicate process, affecting the accessibility of DNA to transcriptional machinery and thus modulating the expression of genes involved in immune responses and inflammation. Similarly, the region encompassing MACROD2 (MACRO Domain Containing 2) and PPIAP17 (Peptidylprolyl Isomerase A Pseudogene 17) is also of interest; MACROD2 is implicated in ADP-ribose metabolism and DNA repair, while PPIAP17 may have regulatory roles. A variant such as rs142441889 near these genes might influence their activity or regulatory elements, potentially impacting cellular stress responses or the immune system’s ability to combat pathogens, as genetic variations are widely recognized to influence disease susceptibility.[5] Such genetic influences are crucial in understanding the complex interplay between host genetics and infectious outcomes.[1] Other variants, such as rs76931343 in PRR16 (Proline Rich 16), may influence protein function or cellular signaling pathways. PRR16 is thought to be involved in various cellular interactions, and a change in its genetic code could affect its stability, localization, or its ability to interact with other proteins, thereby indirectly modulating immune or inflammatory processes. Additionally, ZNF541 (Zinc Finger Protein 541) belongs to a family of proteins known to bind DNA and regulate gene transcription. Variants like rs58219087 within ZNF541could alter its DNA-binding specificity or transcriptional regulatory capacity, potentially impacting the expression of genes that are critical for immune cell development, function, or the body’s response to infection. These kinds of genetic changes highlight how subtle variations can contribute to an individual’s immunological profile and their ability to mount an effective defense against pathogens.[1]Understanding these genetic underpinnings is vital for elucidating disease mechanisms and identifying individuals at higher risk for certain conditions.[6]Further genetic variations affecting fundamental cellular machinery and signaling pathways also contribute to individual differences in infection response.USP39 (Ubiquitin Specific Peptidase 39) is an integral component of the spliceosome, which is essential for processing RNA into mature messenger RNA. A variant like rs192437130 in USP39 could potentially impair splicing efficiency, leading to the production of altered or non-functional proteins, including those critical for immune system integrity. INPP5D(Inositol Polyphosphate-5-Phosphatase D), also known as SHIP1, is a key negative regulator of immune cell signaling, particularly in cells of the hematopoietic system. The variantrs138336976 in INPP5D could impact its enzymatic activity or expression, thus altering crucial signaling cascades that govern immune cell activation, differentiation, and survival, directly affecting the host’s ability to combat infections and manage inflammation. Lastly, ZNF785 and ZNF689 are other zinc finger proteins with likely roles in gene regulation. The variant rs6565193 in the region encompassing these genes could modulate their regulatory functions, potentially influencing the expression of genes vital for immune system development or function. Such genetic variations can modulate an individual’s susceptibility to immune-mediated diseases and their response to infectious agents.[2]These genetic factors contribute to the observed variability in human immune responses and disease outcomes.[7]
Key Variants
Section titled “Key Variants”Manifestations and Phenotypes of Infection
Section titled “Manifestations and Phenotypes of Infection”Infections present with a wide array of clinical phenotypes, ranging from common conditions like chickenpox, cold sores, mononucleosis, strep throat, and scarlet fever to more severe diseases such as tuberculosis, pneumonia, hepatitis, and meningitis.[2] These presentations can be localized, as seen in plantar warts, or systemic, affecting multiple body systems.[1] Detailed, stage-specific phenotypic profiling is crucial for understanding the progression of infectious diseases and identifying precise biological targets and pathogenic mechanisms at different stages.[8]The severity of infection varies greatly, from mild, self-limiting illnesses like the common cold to life-threatening conditions. Patterns of presentation can include acute episodes, recurrent infections, or chronic states. For instance, the frequency of annual common colds or influenza can be cataloged, and individuals with recurrent infections, such as experiencing the same infectious disease multiple times, are often considered to have a higher infectious burden, indicating increased susceptibility.[1] Some infections, like HIV-1, can involve distinct phases of acquisition and control.[9]
Diagnostic Assessment and Biomarkers
Section titled “Diagnostic Assessment and Biomarkers”Diagnosis of infection often relies on a combination of objective and subjective measures. Objective diagnostic tools include serological assays, such as commercially available ELISA assays, which quantify IgG antibody levels against specific pathogens likeC. pneumoniae, H. pylori, CMV, T. gondii, VZV, influenza A and B, HSV-1 and HSV-2, HAV, and HHV-6.[10] The optical density values from these assays, representing quantitative antibody levels, can be inverse-normalized for statistical analysis.[10] For specific infections like Mycobacterium tuberculosis, diagnostic criteria include the presence of positive TST (Tuberculin Skin Test) and QFT-GIT (QuantiFERON-TB Gold In-Tube) test results to define infection, while negative results indicate resistance.[7] Subjective and historical data are also vital, gathered through extensive questionnaires that catalog participants’ history of diseases and hospitalizations, supplemented by available medical records.[1]These records can identify specific diagnoses such as tuberculosis, pneumonia, hepatitis, or meningitis, and can be used to derive broader categories like respiratory infections, gastrointestinal infections, or systemic infections.[1]An “infectious burden” score can be calculated based on the sum of reported infectious diseases and hospitalizations, with adjustments for recurrent infections and conditions like appendectomy or tonsillectomy, which may have heterogeneous origins but are often infection-related.[1]
Heterogeneity and Clinical Significance
Section titled “Heterogeneity and Clinical Significance”The clinical presentation and susceptibility to infection exhibit significant heterogeneity, influenced by factors like age, sex, and individual genetic makeup. For example, age groups studied in some research may be relatively young, impacting the observed lifetime prevalence of infections.[1]While infection phenotypes can be highly specific (e.g., individual ICD-10 codes), studies may also investigate general genetic pathways for susceptibility to any type of infection, acknowledging the diverse nature of infectious disease presentations.[1] This phenotypic diversity underscores the need for precise phenotype definitions in genetic studies to dissect pathogenic mechanisms effectively.[8]The diagnostic significance of infection signs and symptoms, coupled with objective measures, is paramount for clinical management and prognosis. Elevated quantitative IgG antibody levels or a high “pathogen burden”—calculated as the sum of seropositive reactions to multiple pathogens—can serve as indicators of past or chronic exposure and potential susceptibility.[10]Detailed phenotypic profiling, including the assessment of recurrent infections, can identify highly susceptible individuals and may offer advantages in genetic studies for detecting risk factors and understanding disease progression.[1]The validity of infection diagnoses, particularly when sourced from national health registers, is considered high, reinforcing their utility in large-scale epidemiological and genetic investigations.[1]
Causes of Infection
Section titled “Causes of Infection”Infection, a complex physiological state resulting from the invasion and multiplication of pathogens within the host, is influenced by a multifaceted array of genetic, environmental, and host-specific factors. Understanding these underlying causes is crucial given the profound impact infectious diseases have on global health . Once inside, host cells employ various defense mechanisms, such as autophagy, wherePNPLA5 plays a crucial role in autophagosome function and microbial clearance.[11] Furthermore, host cells can actively limit pathogen growth, as seen with mammalian hosts reducing free zinc levels, suggesting a role for zinc transporters like SLC39A8 in nutritional immunity.[12] Viral pathogens, in turn, can manipulate host cellular machinery, with genes like DAPK3 and XRN1 implicated in mediating host mRNA degradation initiated by these invaders.[13]
Immune Response and Inflammatory Pathways
Section titled “Immune Response and Inflammatory Pathways”The host’s immune system is central to combating infection, involving a coordinated network of signaling pathways and key biomolecules. Inflammatory responses are critical, modulated by enzymes such asPDE4B, which is involved in bacteria-induced inflammation.[14] The NF-κβ signaling pathway, enhanced through the interaction of MACROD2 with ARTD10, is vital for increasing inflammation, innate immune responses, and promoting cell survival and proliferation during infection.[1] Additionally, genes like INPPD5 (also known as SHIP1) are closely linked to immune response pathways, including those involving IL10, which collectively influence the clearance of pathogens such as S. aureus.[1] The adaptive immune system also plays a key role, where HLA class I molecules bind and present bacterial peptides, derived from exogenous proteins internalized via phagocytosis or endocytosis, to T-cells, thereby initiating a targeted immune response.[2]
Genetic Susceptibility and Regulation
Section titled “Genetic Susceptibility and Regulation”Host genetics significantly influence an individual’s susceptibility to infection and the severity of disease. Numerous studies suggest that host genetic factors play a major role in the pathogenesis of most infectious diseases, with specific gene functions and regulatory elements impacting immune competence.[2] For example, the IL4gene has been identified in genome-wide association studies (GWAS) as a significant single-nucleotide polymorphism (SNP) associated with respiratory infections.[1] Genetic variants within the HLAregion, which encodes major histocompatibility complex proteins, show important roles for specific amino acid polymorphisms in determining infection outcomes.[2] Beyond direct immune genes, transcriptional repressors like BCL11B, involved in T-cell development, and MACROD2, whose expression is transcriptionally regulated, highlight the complex genetic control over immune cell function and viral life cycles.[1] Infectious diseases, in turn, exert selective pressure on human genomes, driving genetic adaptation, as evidenced by the shaping of the immune system by Neanderthal admixture.[1]
Systemic Effects and Disease Pathophysiology
Section titled “Systemic Effects and Disease Pathophysiology”Infections can lead to widespread pathophysiological processes, affecting multiple tissues and organs and resulting in systemic consequences. Beyond localized effects, such as Staphylococcus aureusnasal colonization, infections can manifest as diverse conditions like pneumonia, bacterial meningitis, or hepatitis, each with distinct cellular and molecular underpinnings.[15]Inflammation, driven by intertwined microRNA, free radical, cytokine, andp53pathways, is a common pathophysiological hallmark across many infections and can contribute to broader disease mechanisms.[16] Critically, infections can also trigger or exacerbate other complex conditions; for instance, they are postulated to contribute to autoimmune disorders by eliciting immune responses against cross-reactive self-epitopes, initiating a cycle of damage.[2] Furthermore, severe infections and autoimmune diseases have been identified as risk factors for mental disorders, underscoring the profound and interconnected systemic impact of infectious processes on overall human health.[17]
Immune Signaling and Response Pathways
Section titled “Immune Signaling and Response Pathways”The host’s initial response to infection involves intricate immune signaling cascades that activate specific cellular defenses. For example,MACROD2 interacts with ARTD10, which subsequently enhances the NF-κβ signaling pathway, a central regulator of inflammation, innate immune responses, cell survival, and proliferation.[1] Similarly, INPPD5, also known as SHIP1, plays a critical role in immune response, with its function closely linked to IL10 and other important pathways, influencing processes like the clearance of Staphylococcus aureus.[1] T-cell signaling pathways are also significantly enriched in immune response networks, highlighting their importance in mounting effective defenses against various infections.[1] Intracellular signaling further orchestrates immune cell behavior and tissue responses. The phosphorylation of mitogen-activated protein kinases (MAPKs) contributes to the production of interferon γ in response to Mycobacterium tuberculosis, demonstrating a key regulatory step in anti-mycobacterial immunity.[18] Cytokines like IL-9 activate STAT3signaling in human airway smooth muscle cells, leading to the expression ofCCL11 and directly stimulating mucin transcription in respiratory epithelial cells, which are crucial for mucosal defense.[19] Furthermore, PDE4B is involved in modulating bacteria-induced inflammation, while NOD2 plays an important role in the inflammatory responses of microglia and astrocytes, collectively illustrating diverse signaling pathways that govern host-pathogen interactions.[20]
Metabolic Adaptation and Nutritional Defense
Section titled “Metabolic Adaptation and Nutritional Defense”Host metabolic pathways undergo significant shifts during infection, both to fuel immune responses and to limit pathogen growth through strategies like nutritional immunity. A key aspect of host defense involves reducing the availability of essential micronutrients, such as free zinc, to thwart pathogen proliferation.[12] In this context, SLC39A8, a zinc transporter, is plausibly involved in regulating host responses by controlling zinc availability for invading pathogens.[21] Pathogens, in turn, must adapt their own metabolic processes, including energy metabolism, biosynthesis, and catabolism, to thrive within the nutrient-restricted host environment.
Beyond micronutrient sequestration, cellular catabolic processes like autophagy are vital for microbial clearance. For example, PNPLA5 is critical for autophagosome functions, facilitating the degradation of intracellular microbes as part of the host’s innate immune response.[11]The host’s ability to precisely regulate metabolic flux and resource allocation represents a dynamic battleground, determining the success or failure of infection. These metabolic adaptations are tightly controlled by regulatory mechanisms that ensure an appropriate balance between host defense and cellular homeostasis.
Molecular Regulation of Host-Pathogen Interactions
Section titled “Molecular Regulation of Host-Pathogen Interactions”Host susceptibility and resistance to infection are profoundly influenced by intricate molecular regulatory mechanisms, including gene expression control and protein modifications. For instance,BCL11B encodes a transcriptional repressor crucial for T-cell development, highlighting how gene regulation at the transcriptional level can shape the immune repertoire.[21] Furthermore, pathogens can hijack or manipulate host regulatory machinery; viruses, for example, initiate host mRNA degradation, a process that genes like XRN1 and DAPK3 are involved in completing, suggesting their role in susceptibility to bacterial infections like S. aureus.[13] Genetic factors, such as CpG methylation and the reversal of histone lysine trimethylation, also play a role in controlling gene expression and influencing susceptibility or response to infections.[22]Post-translational modifications of proteins are pivotal in fine-tuning cellular responses during infection. TheE3 ubiquitin ligase NEDD4 enhances the killing of membrane-perturbing intracellular bacteria by promoting autophagy, a critical catabolic process for pathogen clearance.[23] Conversely, negative regulatory mechanisms also exist, such as Grb14 acting as a negative regulator of CEACAM3-mediated phagocytosis of pathogenic bacteria, illustrating the complex balance of activating and inhibiting signals that govern host defenses.[24] These molecular switches ensure precise control over immune effector functions and pathogen clearance.
Integrated Cellular Networks and Disease Susceptibility
Section titled “Integrated Cellular Networks and Disease Susceptibility”The outcome of infection is often determined by the systems-level integration of multiple pathways, where crosstalk and network interactions create complex, hierarchical regulatory landscapes. Protein-protein interaction (PPI) networks highlight how various gene products cooperate to influence infection susceptibility.[1] For example, RSF1 interacts with SP100, a protein known for its important role in regulating the immune response to intracellular pathogens, and this interaction can also be exploited by viruses like HBV to increase their transcription.[1] The human leukocyte antigen (HLA) system, with its extensive variation, plays a central role in antigen processing and presentation, fundamentally shaping the adaptive immune response and individual susceptibility to a wide range of infectious diseases.[25]Pathway dysregulation and compensatory mechanisms are central to disease-relevant outcomes and identify potential therapeutic targets. Genes likeAPOBEC1 are involved in both innate and adaptive immunity, contributing to the clearance of pneumococcal pneumonia, suggesting its potential as a therapeutic target.[1] The dual regulation of Bcl-2by human immunodeficiency virus (HIV) can lead to persistent infection ofCD4+ T-cells or monocytic cell lines, illustrating a pathogen’s manipulation of host cell survival pathways.[26] Additionally, treatment with IL-7 can prevent the decline of circulating CD4+T cells during acute SIV infection, demonstrating a compensatory mechanism that could be exploited therapeutically.[27]Genetic susceptibility to infections, influenced by numerous rare variants, suggests that individual differences in these integrated networks contribute significantly to disease risk, offering avenues for targeted interventions.[1]
Genetic Predisposition and Risk Stratification
Section titled “Genetic Predisposition and Risk Stratification”Understanding an individual’s genetic susceptibility to infection holds significant prognostic value for predicting disease outcomes and progression. Research indicates that a polygenic risk score (PRS) for infection, while explaining a modest proportion of variance, can identify individuals at varying levels of risk for acquiring infections, with a notable difference in infection rates between the lowest and highest PRS deciles.[1]This finding suggests a potential for early risk stratification, allowing for targeted preventative strategies or closer monitoring in high-risk groups, though the genetic contribution may be more pronounced in severe infection cases.[1]Further advancing personalized medicine, studies have identified novel rare genetic variants that can predict individualized infection disease risk.[1] These rare variants, which may have strong clinical effects, could serve as invaluable tools for forecasting an individual’s likelihood of being infected with specific pathogens, particularly as infectious agents continue to evolve.[1] Such genetic insights enable clinicians to move beyond general population risk assessments, facilitating more precise interventions tailored to an individual’s unique genetic profile.
Diagnostic and Monitoring Applications
Section titled “Diagnostic and Monitoring Applications”The clinical utility of robust infection phenotyping extends to diagnostic and monitoring strategies. Comprehensive trait definitions, encompassing both specific diagnoses like tuberculosis, pneumonia, and hepatitis, and broader categories such as respiratory, gastrointestinal, or systemic infections, enhance the precision of risk assessment and treatment selection.[1]This detailed classification aids in distinguishing between different types of infections and their underlying causes, which is crucial for effective patient management.
Moreover, innovative approaches to quantifying an individual’s infection history, such as an “infectious burden” score, provide a valuable monitoring strategy.[1] This score, which accounts for the cumulative number and recurrence of various infectious diseases, can help identify highly susceptible individuals who may benefit from intensive surveillance or prophylactic measures.[1] Additionally, the of quantitative IgG antibody levels for a range of infectious agents like C. pneumoniae, H. pylori, and CMV serves as an objective measure of pathogen burden, offering insights into past exposures and immune responses relevant for ongoing patient care.[10]
Infection-Related Comorbidities and Phenotypes
Section titled “Infection-Related Comorbidities and Phenotypes”Infections are frequently associated with a range of comorbidities and overlapping phenotypes, significantly impacting patient care. A strong epidemiological and genetic correlation has been observed between susceptibility to infection and mental disorders, with individuals having psychiatric diagnoses showing a notably increased prevalence of infections.[1] This association holds true across various specific psychiatric conditions, highlighting a complex interplay that necessitates integrated care approaches.[1]Beyond mental health, specific genetic factors link infection susceptibility to broader physiological processes. For instance, thers6447952 variant in the SLIT2gene, associated with infection, is known to play a role in both immunity and neurodevelopment, suggesting common genetic pathways influencing these seemingly disparate conditions.[1]Furthermore, conditions like appendectomy and tonsillectomy, though heterogeneous in origin, are often included in broader infection-related trait definitions due to their established associations with infectious processes, underscoring the interconnectedness of various clinical presentations.[1]
Frequently Asked Questions About Infection
Section titled “Frequently Asked Questions About Infection”These questions address the most important and specific aspects of infection based on current genetic research.
1. Why do I always catch colds, but my partner rarely does?
Section titled “1. Why do I always catch colds, but my partner rarely does?”Your individual genetic makeup significantly influences how susceptible you are to infections like colds. Research shows that many genes work together to determine your immune response, meaning some people are naturally more resistant to certain pathogens due to their unique genetic variants. These differences dictate how your body interacts with and fights off invading microorganisms.
2. If my parents get sick often, will I too?
Section titled “2. If my parents get sick often, will I too?”Yes, there’s a good chance you might share some susceptibility. Your host genetic factors, inherited from your parents, play a significant role in determining your risk for various infections. While it’s not a guarantee, genetic variants associated with infection risk can accumulate within families, influencing how your immune system responds to pathogens.
3. Could a DNA test tell me which infections I’m prone to?
Section titled “3. Could a DNA test tell me which infections I’m prone to?”Yes, increasingly so. Identifying specific genetic variants, especially rare ones, can be an invaluable tool for predicting your individualized risk of certain infections. This information could potentially guide personalized preventive measures or closer monitoring for you.
4. Can I boost my immunity enough to overcome bad genes?
Section titled “4. Can I boost my immunity enough to overcome bad genes?”While genetics play a significant role, lifestyle and environment are also crucial. Understanding your genetic predisposition can help guide targeted interventions and preventive measures. For example, if you know you’re at higher risk for certain infections, you might focus more on vaccinations or specific hygiene practices to reduce your exposure and bolster your immune response.
5. Does my family’s background affect my infection risk?
Section titled “5. Does my family’s background affect my infection risk?”Yes, your ancestral background can certainly influence your infection risk. Genetic variations are not uniformly distributed across populations, meaning variants common in one ethnic group might be rare in another. Therefore, findings on infection susceptibility in one population may not fully apply to yours, highlighting the importance of diverse genetic studies.
6. Has modern medicine made our genes weaker against sickness?
Section titled “6. Has modern medicine made our genes weaker against sickness?”In a way, yes. Historically, severe infections acted as strong selective pressures, removing individuals most susceptible to disease. With mandatory vaccinations, improved sanitation, and better treatments, these pressures have shifted. This has led to the retention and accumulation of certain genetic variants associated with disease susceptibility within populations, which might have been selected against in the past.
7. Why do I get cold sores more than my friends?
Section titled “7. Why do I get cold sores more than my friends?”Your genetic profile likely influences your susceptibility to specific infections like cold sores. Studies have identified various genetic regions associated with common infections, and individual variations in these genes can make you more prone to frequent outbreaks compared to others. For instance, specific regions within the Human Leukocyte Antigen (HLA) region are known to play a critical role in immune response.
8. Could getting sick often affect my mental health?
Section titled “8. Could getting sick often affect my mental health?”Emerging research suggests a potential link between susceptibility to infection and other health conditions, including mental disorders. While the exact mechanisms are still being explored, genetic factors that influence your immune response and infection risk might also play a role in your overall health and well-being, including mental health.
9. If I’m high risk, what can I do to avoid getting sick?
Section titled “9. If I’m high risk, what can I do to avoid getting sick?”Identifying your genetic risk can help tailor preventive measures. If you’re found to have a higher genetic susceptibility, you might benefit from more rigorous preventive strategies, personalized treatment plans, or closer monitoring. This could include specific vaccinations, enhanced hygiene, or avoiding certain exposures to reduce your risk.
10. Are we more vulnerable to new diseases than before?
Section titled “10. Are we more vulnerable to new diseases than before?”The shift in selective pressures due to modern medicine has led to the retention of genetic variants that might have been less common historically. While we have advanced clinical treatments, this accumulation of certain susceptibility variants means understanding your genetic pathways is crucial for managing potential (re-)emerging epidemics.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Gelemanovic A. “Genome-Wide Meta-Analysis Identifies Multiple Novel Rare Variants to Predict Common Human Infectious Diseases Risk.” Int J Mol Sci. 2023;24:7006.
[2] Tian, C et al. “Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections.” Nature Communications, vol. 8, no. 1, 2017, p. 676.
[3] Nudel, R et al. “A large-scale genomic investigation of susceptibility to infection and its association with mental disorders in the Danish population.”Translational Psychiatry, vol. 9, no. 1, 2019, p. 297.
[4] Wellcome Trust Case Control Consortium. “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.” Nature. PMID: 17554300.
[5] McLaren, P. J., et al. “Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.” PLoS Pathog, vol. 9, no. 8, 2013, e1003513.
[6] Albright, F. S., et al. “Evidence for a Heritable Predisposition to Death Due to Influenza.” J. Infect. Dis., vol. 197, 2008, pp. 18–24.
[7] Quistrebert, J., et al. “Genome-wide association study of resistance to Mycobacterium tuberculosis infection identifies a locus at 10q26.2 in three distinct populations.”PLoS Genet, vol. 17, no. 3, 2021, e1009491.
[8] Luo, Y., et al. “Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians.”Nat Commun, vol. 10, no. 1, 2019, p. 3782.
[9] Fellay, J., et al. “Common genetic variation and the control of HIV-1 in humans.” PLoS Genet, vol. 6, no. 1, 2010.
[10] Rubicz, R. et al. “A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).” PLoS Genet 9.1 (2013): e1003169.
[11] Dupont, N., Chauhan, S., Arko-Mensah, J., Castillo, E. F., Masedunskas, A., Weigert, R., et al. “Neutral lipid stores and lipase PNPLA5.” 10.1016/j.cub.2014.02.008.
[12] Kehl-Fie, T. E., and E. P. Skaar. “Nutritional Immunity Beyond Iron: A Role for Zinc.” Current Opinion in Chemical Biology, vol. 14, no. 2, 2010, pp. 240-246.
[13] Gaglia, M. M., Covarrubias, S., Wong, W., and Glaunsinger, B. A. “A common strategy for host RNA degradation by divergent viruses.” J. Virol. 86, 2012.
[14] Komatsu K, Lee J Y, Miyata M, Hyang Lim, J, Jono, H, Koga, T, et al. “Inhibition of PDE4B suppresses inflammation by increasing expression of the.”
[15] Kuehnert, M. J., et al. “Prevalence of Staphylococcus Aureus Nasal Colonization in the United States, 2001–2002.” J. Infect. Dis., vol. 193, no. 2, 2006, pp. 241–248.
[16] Schetter, A. J. et al. “Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.”Carcinogenesis 31.1 (2010): 37–49.
[17] Benros, M. E. et al. “Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.” JAMA Psychiatry 70 (2013): 812–820.
[18] Pasquinelli V, Rovetta AI, Alvarez IB, Jurado JO, Musella RM, Palmero DJ, et al. “Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to mycobacterium tuberculosis.” J Infect.
[19] Longphre M, Li D, Gallup M, Drori E, Ordonez CL, Redman T, et al. “Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells.” The Journal of clinical investigation. 1999; 104.
[20] Chauhan VS, Sterka DG, Furr SR, Young AB, Marriott I. “NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to.”
[21] Ye Z. “Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections.” Front Genet. 2014.
[22] Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, et al. “CpG methylation controls.”
[23] Pei G, Buijze H, Liu H, et al. “The E3 ubiquitin ligase NEDD4 enhances killing of membrane-perturbing intracellular bacteria by promoting autophagy.” Autophagy. 2017;13(12):2041-2055.
[24] Kopp K, Buntru A, Pils S, et al. “Grb14 is a negative regulator of CEACAM3-mediated phagocytosis of pathogenic bacteria.” J Biol Chem. 2012;287(46):39158-39170.
[25] Blum JS, Wearsch PA, Cresswell P. “Pathways of antigen process-ing.” Annu Rev Immunol. 2013;31:443-473.
[26] Aillet F, Masutani H, Elbim C, Raoul H, Chene L, et al. “Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines.” J Virol 72, 1998.
[27] Vassena L, Miao H, Cimbro R, Malnati MS, Cassina G, et al. “Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques.” PLoS. 2012.